Cerus (CERS) Stock Highlights

1.58 | +0%

2024-12-21 05:53:29

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Statistics

Range Today

1.55 1.64

Volume Today 2.38M

Range 1 Year

1.38 2.59

Volume 1 Year 321.66M

Range 3 Year

1.21 7.08

Volume 3 Year 1.07B

Range 10 Year

1.21 8.87

Volume 10 Year 3.25B

Highlights

Market Capitalization 330.57M (small)

Floating Shares 157.72M

Current Price 1.58

Price To Earnings -16

Price To Revenue 2.01

Price To Book 6.18

Earnings Per Share -0.11

Payout Ratio 0%

Performance

Latest 0%

1 Month -4.82%

3 Months -14.13%

6 Months -5.95%

1 Year -32.77%

3 Years -75.88%

5 Years -61.93%

10 Years -75.39%

Benchmarks

Market Capitalization

179 / 368

Gross Profits

48 / 278

Total Revenue

72 / 300

Total Rank

22 / 368

Free Cashflow

102 / 352

Performance 5 years

186 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.